| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,028 | $88.64 | $534,331.34 | -0.4% | +17.4% | +56.8% | |
| Mar 5, 2024 | A Agilent Technologies, Inc. | Fields Heidi | Director | Sell | 1,658 | $144.34 | $239,315.72 | -2.9% | -9.0% | -12.4% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,826 | $88.37 | $249,719.49 | -3.8% | +23.6% | +68.8% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 191,012 | $87.40 | $16,694,485.32 | -3.2% | +23.6% | +68.8% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 2,160 | $88.37 | $190,868.40 | -1.0% | +23.6% | +68.8% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 9,326 | $88.37 | $824,091.99 | -3.6% | +23.6% | +68.8% | |
| Mar 5, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | -3.4% | -18.5% | |
| Mar 5, 2024 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | -3.4% | -18.5% | |
| Mar 5, 2024 | WGS Genedx Holdings Corp. | Casdin Capital, LLC97 | Director, 10% Owner | Buy | 40,900 | $8.74 | $357,652.30 | +0.8% | +145.7% | +1106.3% | |
| Mar 5, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,131 | $21.41 | $88,461.23 | -5.3% | +4.9% | -4.4% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,245 | $88.36 | $198,360.72 | -0.6% | +23.6% | +68.8% | |
| Mar 5, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,838 | $88.36 | $162,399.87 | -0.8% | +23.6% | +68.8% | |
| Mar 4, 2024 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 16,594,363 | $14.31 | $237,423,848.62 | -15.7% | -21.5% | -21.4% | |
| Mar 4, 2024 | NEO Neogenomics Inc | Tetrault Lynn A. | Director | Sell | 6,112 | $15.97 | $97,578.69 | -10.9% | -15.9% | -41.9% | |
| Mar 4, 2024 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $19.05 | $1,905.00 | -2.2% | +44.9% | +119.2% | |
| Mar 4, 2024 | SHC Sotera Health Co | Klee Ann R. | Director | Sell | 5,750 | $14.31 | $82,268.13 | -6.2% | -21.5% | -21.4% | |
| Mar 4, 2024 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 2,750 | $261.05 | $717,890.00 | -14.2% | -19.7% | -36.5% | |
| Mar 4, 2024 | SHC Sotera Health Co | Gtcr Investment XI LLC74 | Director, 10% Owner | Sell | 11,062,908 | $14.31 | $158,282,556.21 | -15.7% | -21.5% | -21.4% | |
| Mar 4, 2024 | XGN Exagen Inc. | Adawi Kamal | CFO And Corporate Secretary | Sell | 12,784 | $1.91 | $24,406.86 | -2.5% | +3.7% | +58.4% | |
| Mar 4, 2024 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | President | Sell | 22,321 | $403.03 | $8,996,032.63 | -85.4% | -3.2% | -19.4% | |
| Mar 4, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 23,323 | $20.68 | $482,285.44 | -10.0% | +10.2% | +4.7% | |
| Mar 4, 2024 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 16,594,363 | $14.31 | $237,423,848.62 | -15.7% | -21.5% | -21.4% | |
| Mar 4, 2024 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 400 | $1,278.73 | $511,492.00 | -35.3% | +8.8% | -3.5% | |
| Mar 4, 2024 | SHC Sotera Health Co | Petras Michael B. Jr.68 | Chairman &CEO | Sell | 1,003,870 | $14.31 | $14,362,870.02 | -15.5% | -21.5% | -21.4% | |
| Mar 4, 2024 | SHC Sotera Health Co | Rutz Michael P68 | President Of Sterigenics | Sell | 83,109 | $14.31 | $1,189,082.02 | -13.2% | -21.5% | -21.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.